4.5 Article

The Adaptor Protein p66Shc Inhibits mTOR-Dependent Anabolic Metabolism

Journal

SCIENCE SIGNALING
Volume 7, Issue 313, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scisignal.2004785

Keywords

-

Funding

  1. Genome Canada through the Ontario Genomics Institute
  2. Ontario Research Fund Global Leadership Round in Genomics Life Sciences [ORF-GL2]
  3. Canadian Cancer Society
  4. Canadian Institutes of Health Research [MOP-62975]
  5. Sydney C. Cooper Program
  6. Canada Research Chairs Program
  7. Canadian Institute of Health Research [MOP-49409]
  8. Department of Defense
  9. Keck and LAM Foundation
  10. MITACS-accelerate
  11. National Science and Technology Council, CONACYT, Mexico
  12. Ruth Kirschstein National Research Service [NIH K99]
  13. Vanier Canada Graduate Scholarship
  14. Ontario Graduate Scholarship

Ask authors/readers for more resources

Adaptor proteins link surface receptors to intracellular signaling pathways and potentially control the way cells respond to nutrient availability. Mice deficient in p66Shc, the most recently evolved isoform of the Shc1 adaptor proteins and a mediator of receptor tyrosine kinase signaling, display resistance to diabetes and obesity. Using quantitative mass spectrometry, we found that p66Shc inhibited glucose metabolism. Depletion of p66Shc enhanced glycolysis and increased the allocation of glucose-derived carbon into anabolic metabolism, characteristics of a metabolic shift called the Warburg effect. This change in metabolism was mediated by the mammalian target of rapamycin (mTOR) because inhibition of mTOR with rapamycin reversed the glycolytic phenotype caused by p66Shc deficiency. Thus, unlike the other isoforms of Shc1, p66Shc appears to antagonize insulin and mTOR signaling, which limits glucose uptake and metabolism. Our results identify a critical inhibitory role for p66Shc in anabolic metabolism.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Regulation of metabolic health by dietary histidine in mice

Victoria Flores, Alexandra B. Spicer, Michelle M. Sonsalla, Nicole E. Richardson, Deyang Yu, Grace E. Sheridan, Michaela E. Trautman, Reji Babygirija, Eunhae P. Cheng, Jennifer M. Rojas, Shany E. Yang, Matthew H. Wakai, Ryan Hubbell, Ildiko Kasza, Jay L. Tomasiewicz, Cara L. Green, Claudia Dantoin, Caroline M. Alexander, Joseph A. Baur, Kristen C. Malecki, Dudley W. Lamming

Summary: This study demonstrates that reducing dietary histidine levels can lead to weight loss, decreased fat and muscle mass, and improved metabolic health in male mice. The findings suggest that reducing dietary histidine may be a potential option for the treatment of obesity in humans.

JOURNAL OF PHYSIOLOGY-LONDON (2023)

Article Biochemistry & Molecular Biology

Multi-Omics Profiling in PGM3 and STAT3 Deficiencies: A Tale of Two Patients

Minnie Jacob, Afshan Masood, Anas M. Abdel Rahman

Summary: Hyper-IgE Syndrome (HIES) is a group of primary immune-deficiency disorders characterized by high levels of IgE, eczema, and recurrent skin and lung infections. HIES can be caused by mutations in the STAT3 and PGM3 genes. Detecting HIES early is challenging but can be done through clinical suspicion and immunological assessments. Metabolomics, proteomics, and cytokine profiles of HIES patients were compared to patients with other immune-related conditions. Dysregulation of metabolites and proteins, as well as cytokine dysregulation, were observed in both STAT3 and PGM3 patients, indicating potential biomarkers for diagnosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Untargeted Metabolomics Identifies Biomarkers for MCADD Neonates in Dried Blood Spots

Rajaa Sebaa, Maha AlMogren, Wafaa Alseraty, Anas Abdel M. Rahman

Summary: Medium-chain acyl-CoA dehydrogenase deficiency (MCADD) is a common mitochondrial metabolic disease in newborns. Current diagnostic methods have limitations, so complementary approaches are needed. Untargeted metabolomics analysis of MCADD newborns and healthy controls identified potential metabolic biomarkers/pathways associated with MCADD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Metabolic sensing and control in mitochondria

Yuyang Liu, Kivanc Birsoy

Summary: Mitochondria are organelles with their own genomes and unique biochemical reaction networks. They must maintain a specific biochemical environment and coordinate with the host cell's metabolic networks. This coordination involves sensing and controlling metabolites and responding to metabolic stresses. Dysfunction in the regulatory circuits of mitochondrial metabolic sensing and control can lead to metabolic disorders with clinical manifestations. This review discusses the logic and molecular basis of metabolic sensing and control in mitochondria, highlighting gaps in current knowledge that can potentially be addressed with emerging technologies.

MOLECULAR CELL (2023)

Review Geriatrics & Gerontology

Geroprotective interventions in the 3xTg mouse model of Alzheimer's disease

Michelle M. M. Sonsalla, Dudley W. W. Lamming

Summary: Alzheimer's disease (AD) is an age-associated neurodegenerative disease with increasing prevalence due to the aging population. Traditional drug development efforts for AD have been largely unsuccessful. However, targeting aging itself through geroprotective interventions shows potential for preventing or treating AD.

GEROSCIENCE (2023)

Article Biochemistry & Molecular Biology

A Distinctive Metabolomics Profile and Potential Biomarkers for Very Long Acylcarnitine Dehydrogenase Deficiency (VLCADD) Diagnosis in Newborns

Rajaa Sebaa, Reem H. AlMalki, Wafaa Alseraty, Anas Abdel M. Rahman

Summary: Very long-chain acylcarnitine dehydrogenase deficiency (VLCADD) is a rare inherited metabolic disorder characterized by genetic mutations and accumulations of acylcarnitines. Current diagnostic methods have limitations, and additional tools are needed for improved performance. Metabolomics analysis identified distinct metabolic profiles and potential biomarkers for VLCADD diagnosis.

METABOLITES (2023)

Article Endocrinology & Metabolism

Metabolomic profile of patients on levothyroxine treatment for hypothyroidism

Hicham Benabdelkamel, Malak A. Jaber, Lina A. Dahabiyeh, Afshan Masood, Reem H. Almalki, Mohthash Musambil, Anas M. Abdel Rahman, Assim A. Alfadda

Summary: In this study, the metabolic changes in the plasma of patients with hypothyroidism after levothyroxine treatment were explored using metabolomics techniques. The findings revealed significant changes in multiple metabolites, lipids, and bile acids, providing valuable insights into the pathophysiology and therapeutic effects of levothyroxine on hypothyroidism at the molecular level.

EUROPEAN THYROID JOURNAL (2023)

Article Medical Laboratory Technology

Quantitative analysis of soluble costimulatory molecules as potential diagnostic biomarkers for rheumatoid arthritis using LC-MS/MS in MRM mode

Abeer K. Malkawi, Refat M. Nimer, Maha Almogren, Afshan Masood, Abdulrahman S. Alarfaj, Hicham Benabdelkamel, Anas M. Abdel Rahman, Mohamed Siaj

Summary: This study developed a novel liquid chromatography-tandem mass spectrometry method to accurately quantify soluble costimulatory molecules in human plasma as potential diagnostic biomarkers for rheumatoid arthritis (RA). The method showed a wide linear range and met international standards for reliability and accuracy. The plasma levels of sCTLA4, sCD80, and sCD86 were significantly elevated in RA patients, with sCTLA4 showing the highest diagnostic and clinical performance.

CLINICA CHIMICA ACTA (2023)

Article Biochemistry & Molecular Biology

Metabolic Alteration of MCF-7 Cells upon Indirect Exposure to E. coli Secretome: A Model of Studying the Microbiota Effect on Human Breast Tissue

Reem H. Almalki, Malak A. Jaber, Mysoon M. Al-Ansari, Khalid M. Sumaily, Monther Al-Alwan, Essa M. Sabi, Abeer K. Malkawi, Anas M. Abdel Rahman

Summary: According to studies, the microbiome, specifically E. coli, can alter the metabolism of breast cancer cells through its secretome by disrupting key metabolic pathways. Liquid chromatography-mass spectrometry (LC-MS) metabolomics was used to analyze the intracellular and extracellular metabolites of MCF-7 cells exposed to E. coli secretome. Significant alterations in 31 intracellular and 55 extracellular metabolites were observed, indicating the dysregulation of several metabolic pathways. These microbial metabolites from the secretome hold promise as biomarkers for drug resistance or innovative approaches for cancer treatment.

METABOLITES (2023)

Article Biochemistry & Molecular Biology

Targeted Metabolomics Analysis of Individuals Carrying the ANGPTL8 R59W Variant

Mohamed Abu-Farha, Shibu Joseph, Anwar Mohammad, Arshad Channanath, Ibrahim Taher, Fahd Al-Mulla, Muhammad Mujammami, Thangavel Alphonse Thanaraj, Jehad Abubaker, Anas M. Abdel Rahman

Summary: This study used metabolomics to investigate the impact of the ANGPTL8 R59W variant on metabolites in Arab individuals. The results showed significant associations between the variant and concentrations of lipid- and inflammation-related metabolites, highlighting the importance of this gene in lipid metabolism.

METABOLITES (2023)

Article Chemistry, Medicinal

Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin

Awad Alshahrani, Ahmad Aljada, Afshan Masood, Muhammad Mujammami, Assim A. Alfadda, Mohthash Musambil, Ibrahim O. Alanazi, Mohammed Al Dubayee, Anas M. Abdel Rahman, Hicham Benabdelkamel

Summary: This study explores the proteomic changes associated with metformin treatment in obese patients (with or without T2DM) using a proteomic approach. The results suggest that metformin may alter the expression of potential biomarkers through pathways involving acute-phase response, inflammation, and oxidative response, which contributes to the understanding of metformin's mechanisms of action.

PHARMACEUTICALS (2023)

Article Multidisciplinary Sciences

Demaghi, a polyherbal formulation, mitigates aluminum chloride-induced neurological impairment in mice: Insights from phytochemical analysis and behavioral assessment

Hassan Ali, Hafiz Usman, Waseem Ashraf, Faleh Alqahtani, Sana Javaid, Farhan Siddique, Muhammad Fawad Rasool, Imran Imran, Tanveer Ahmad, Anas M. Abdel Rahman, Reem H. Almalki

Summary: This study scientifically validates the neuroprotective effects of the herbal product Demaghi, which is claimed to have memory-enhancing properties. The results show that Demaghi reduces anxiety and depression and improves memory in a mouse model of memory deficiency induced by AlCl3. Biochemical analysis also indicates a decrease in oxidative stress and histopathological changes in treated animals. These findings suggest that the phytoconstituents in Demaghi enhance cholinergic neurotransmission and protect against neurotoxin-induced oxidative stress.

HELIYON (2023)

Review Cell Biology

Targeting the biology of aging with mTOR inhibitors

Joan B. Mannick, Dudley W. Lamming

Summary: Lamming and Mannick discuss the research in the past decade showing the survival-promoting effects of rapamycin in multiple species and the recent clinical trials exploring the use of existing mTOR inhibitors in preventing, delaying or treating aging-related diseases in humans.

NATURE AGING (2023)

Article Biophysics

A diagnostic electrochemical aptasensor development for sCD80 protein detection in human serum

Abeer K. Malkawi, Maziar Jafari, Leanne Ohlund, Lekha Sleno, Anas M. Abdel Rahman, Mohamed Siaj

Summary: In this study, a sensitive aptasensor was developed to detect sCD80 in human serum. A high-affinity aptamer was selected through conventional in-vitro selection process and immobilized on a screen-printed gold electrode. The aptasensor showed good assembly and distribution performance, with linear detection range and low detection limit. The sensor also demonstrated reliable performance in a biological matrix.

BIOSENSORS & BIOELECTRONICS (2023)

Article Biochemistry & Molecular Biology

Proteomics Investigation of the Impact of the Enterococcus faecalis Secretome on MCF-7 Tumor Cells

Moudi A. Alwehaibi, Mysoon M. Al-Ansari, Assim A. Alfadda, Reem Al-Malki, Afshan Masood, Anas M. Abdel Rahman, Hicham Benabdelkamel

Summary: This study investigated the effects of Enterococcus faecalis on breast cancer cells and identified changes in the proteomic profiles of the cells after treatment. Several proteins were found to be potential markers for breast cancer treatment and diagnosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

No Data Available